W

Eli Lilly is suing pharmacies and peptide vendors over sale of its next big weight-loss drug: retatrutide

商业管理
分享到
Eli Lilly is suing pharmacies and peptide vendors over sale of its next big weight-loss drug: retatrutide

Some Americans have turned to medical spas and pharmacies that sell peptides for health and wellness benefits for access to compounded versions of retatrutide.

Eli Lilly is suing pharmacies and peptide vendors over sale of its next big weight-loss drug: retatrutide


Source:MarketWatch

友情提醒:请广大读者理性看待市场信息,切实提高风险意识。站内所有内容仅系市场信息或相关方观点,不构成任何形式投资建议。

延伸阅读

A ‘death cross’ is coming for the dollar. Why Trump will be happy.

Don’t look now, but there are some technical reasons to believe that U.S. Treasury Secretary Scott Bessent was right when he declared to the financial markets…

Another appeals court rules against prediction market provider Kalshi, says sports contracts are subject to state regulations

A Sixth Circuit Court of Appeals panel ruled that prediction markets' sportsrelated events contracts are not swaps, and therefore aren't subject to federal…

OG.com seeks CFTC approval for single-stock perpetual futures

OG.com, recently spun out of Crypto.com, joins Coinbase, Kalshi and Kraken parent Payward in seeking approval to bring perpetual futures to individual US…

Federal Reserve Board announces approval of application by Peoples Bancorp Inc.

Federal Reserve Board announces approval of application by Peoples Bancorp Inc. Source:Federal Reserve

来源:https://www.marketwatch.com/story/eli-lilly-is-suing-pharmacies-and-peptide-vendors-over-sales-of-the-next-big-weight-loss-drug-retatrutide-22434cce